awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34657338-F82D0D53-3315-4B7D-B140-048B90B535BE
Q34657338-F82D0D53-3315-4B7D-B140-048B90B535BE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34657338-F82D0D53-3315-4B7D-B140-048B90B535BE
A phase II study of GW786034 (pazopanib) with or without bicalutamide in patients with castration-resistant prostate cancer
P2860
Q34657338-F82D0D53-3315-4B7D-B140-048B90B535BE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34657338-F82D0D53-3315-4B7D-B140-048B90B535BE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f7320ee8b4b92792579bd6809a758f1cd0e26e0a
P2860
Measuring therapeutic efficacy in the changing paradigm of castrate-resistant prostate cancer.